Founded in 2020, TOXPLUS partners with biotechnology and pharmaceutical organizations to deliver end-to-end support across the non-clinical phase of drug development. The company brings together a team with decades of hands-on experience managing and auditing CROs worldwide. TOXPLUS helps clients design, monitor, and validate pharmacology and toxicology studies, ensuring data integrity, compliance, and regulatory readiness. Their mission is to reduce program risk and improve study outcomes through independent oversight and expert guidance.

Why They Stand Out
TOXPLUS is not just a CRO—it’s an expert oversight partner ensuring that every non-clinical study meets the highest scientific and regulatory standards. Their team has managed and audited hundreds of global CROs, giving them a unique perspective on how to anticipate risks and drive operational excellence. By combining regulatory insight with on-the-ground monitoring, TOXPLUS enables sponsors to focus on program strategy while maintaining confidence in study execution.

Ideal Fit for CROaccess Users

Early-stage biotech companies seeking independent non-clinical oversight and regulatory guidance.

Sponsors managing multiple CRO vendors and needing centralized quality and compliance coordination.

Academic and translational researchers advancing preclinical studies toward IND submission.

Pharma companies outsourcing toxicology and pharmacology but requiring third-party audits or data verification.